Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
Open Access
Abstract
The approval of immune checkpoint inhibitors has expanded treatment options for renal cell carcinoma (RCC), but new therapies that target RCC stemness and promote anti-tumor immunity are needed. Previous findings demonstrate that doublecortin-like kinase 1 (DCLK1) regulates stemness and is associated with RCC disease progression. Herein, we demonstrate that small-molecule kinase inhibitor DCLK1-IN-1 strongly inhibits DCLK1 phosphorylation and downregulates pluripotency factors and cancer stem cell (CSC) or epithelial-mesenchymal transition (EMT)-associated markers including c-MET, c-MYC, and N-Cadherin in RCC cell lines. Functionally, DCLK1-IN-1 treatment resulted in significantly reduced colony formation, migration, and invasion. Additionally, assays using floating or Matrigel spheroid protocols demonstrated potent inhibition of stemness. An analysis of clinical populations showed that DCLK1 predicts RCC survival and that its expression is correlated with reduced CD8+ cytotoxic T-cell infiltration and increases in M2 immunosuppressive macrophage populations. The treatment of RCC cells with DCLK1-IN-1 significantly reduced the expression of immune checkpoint ligand PD-L1, and co-culture assays using peripheral blood monocytes (PBMCs) or T-cell expanded PBMCs demonstrated a significant increase in immune-mediated cytotoxicity alone or in combination with anti-PD1 therapy. Together, these findings demonstrate broad susceptibility to DCLK1 kinase inhibition in RCC using DCLK1-IN-1 and provide the first direct evidence for DCLK1-IN-1 as an immuno-oncology agent.Keywords
This publication has 46 references indexed in Scilit:
- XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanismCancer Letters, 2014
- Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1Molecular Cancer, 2014
- Long-lived intestinal tuft cells serve as colon cancer–initiating cellsJournal of Clinical Investigation, 2014
- Brief Report: Dclk1 Deletion in Tuft Cells Results in Impaired Epithelial Repair After Radiation InjuryStem Cells, 2013
- DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic CancerPLOS ONE, 2013
- Dclk1 distinguishes between tumor and normal stem cells in the intestineNature Genetics, 2012
- Lineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal AdenomasScience, 2012
- The intestinal epithelium tuft cells: specification and functionCellular and Molecular Life Sciences, 2012
- Ammonia-containing dimethyl sulfoxide: An improved solvent for the dissolution of formazan crystals in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assayAnalytical Biochemistry, 2012
- On the exact distribution of maximally selected rank statisticsComputational Statistics & Data Analysis, 2003